deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01508468

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (GEMRITUX)

Prospective Randomized Multicentric Open Label Study to Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (IMN)

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Idiopathic Membranous Nephropathy
Interventions experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
Updated 7 times since 2017 Last updated: Oct 18, 2021 Started: Jan 17, 2012 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01508468, this PHASE3 trial focuses on Idiopathic Membranous Nephropathy and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotUnknown Status~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotUnknown Status~Nov 2021 – ~Jul 2024 · 32 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Nov 2021 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  4. Jan 2021 — Nov 2021 [monthly]

    Unknown Status PHASE3

  5. Sep 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assistance Publique - Hôpitaux de Paris
Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations